Article Text

Concentrations of angiotensin II, endothelin-1, and BNP in the coronary sinus and ascending aorta of patients with heart disease
  1. YUTAKA KAGAYA,
  2. HIROKI OTANI,
  3. TOSHINORI TANIKAWA,
  4. SHIGETO NAMIUCHI,
  5. SHOGEN ISOYAMA,
  6. KUNIO SHIRATO
  1. First Department of Internal Medicine,
  2. Tohoku University School of Medicine,
  3. 1–1 Seiryo-machi, Aoba-ku, Sendai, 980–8574 Japan
  4. email: kagaya@int1.med.tohoku.ac.jp

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Sir,—It has been well documented that neurohormonal mediators, such as the renin–angiotensin system,1 endothelin,2 and brain natriuretic peptide (BNP),3 are severely activated in patients with congestive heart failure, and that the circulating concentrations of these mediators are good predictors of the severity of congestive heart failure and the prognosis. It has also been demonstrated that both angiotensin II and endothelin-1, like BNP, are locally expressed in cardiac tissue.4-6 It is not clear, however, whether the increase in plasma concentrations of angiotensin II and endothelin-1 is caused by increased expression and spillover from cardiac tissue in patients with …

View Full Text